ArticleBioactive materials2025
Trimetallic Pt-Pd-Au alloy nanozymes for multimodal synergistic therapy to overcome deep-seated drug-resistant infections via ROS cascade.
Article in Bioactive materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Recent advances in multidimensionally regulated nanozyme-integrated biosensors for rapid and ultrasensitive foodborne mycotoxin detection.Archives of toxicology · 2026Review
- Advances in ultrasound-mediated nanozyme systems in therapeutic applications.Ultrasonics sonochemistry · 2026Review
- Composite Hydrogel Loading Polysaccharides Derived fromBiomolecules · 2026Article
- Nanozymes for ferroptosis-based cancer theranostics.Bioactive materials · 2026Review
- NIR-Triggered On-Demand Synergistic Therapy for Multidrug-Resistant Bacterial Infections Via a Smart Phase-Transition Hydrogel.Advanced healthcare materials · 2026Article
- A Self-Cascading Immunomodulatory Hydrogel for Remodeling Infected Diabetic Wounds.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Dual RONS-responsive chemiluminescence-guided multimodal thrombolysis based on an aggregation-induced emission cobalt-porphyrin nanoplatform.Chemical science · 2026Article
- Aptamer-guided upconversion nanoconstructs enable proximity-dependent and precise photodynamic therapy for MRSA-infected wounds.Materials today. Bio · 2026Article
- TeSe nanoparticle-integrated exosomes for accelerated diabetic Pressure ulcer healing via NIR-II triggered synergy.Biomaterials and biosystems · 2026Article
- A photocuring double-network hydrogel enhances mechanotransduction and scavenges ROS to accelerate pressure injury healing.Materials today. Bio · 2026Article
- Extracellular Vesicle-embedded alginate hydrogel patch for accelerated wound healing.Materials today. Bio · 2026Article
- NIR-II-triggered copper single-atom catalyst depots coupling catalysis and drug release for infected chronic wounds with dysregulated inflammation.Materials today. Bio · 2026Article
- Global research trends and emerging frontiers of nanozymes in cancer therapy based on bibliometric and knowledge mapping analysis from 2001 to 2025.Discover nano · 2026Review
- Near-infrared light-driven photocatalytic reactive oxygen species-generating antibacterial and self-shrinking hybrid hydrogels for combating drug-resistant bacterial biofilm infection and accelerating wound healing.Bioactive materials · 2026Article
- pH-responsive printable conductive hydrogels loaded with ApoVs promote diabetic wound repair through oxidative stress scavenging and macrophage reprogramming.Materials today. Bio · 2026Article
- Harnessing NIR-II-responsive Rh single-atom nanozymes for photothermal-catalytic immunomodulation and eradication of drug-resistant biofilms in deep tissues.Materials today. Bio · 2026Article
- The enhanced photothermal therapy against gastric cancer by mitochondria/STAT3-targeted nanoplatform with OXPHOS blocking.Materials today. Bio · 2026Article
- Immunomodulatory hydrogel reprograms IL-17/NF-κB signaling to drive regeneration in diabetic wounds.Materials today. Bio · 2026Article
- Microglial Membranes Wrapped Ultrasmall Medium-Entropy Ru Single-Atom Nanozyme: Enhanced Catalysis for Accelerating Inflammation/Redox Microenvironment Regulation in Intracerebral Hemorrhage.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Metal-Functionalized Nanozymes in Antibacterial Wound Management: Recent Advances and Future Perspectives.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To address the therapeutic challenges posed by deep-tissue drug-resistant bacterial infections, this study innovatively develops a multimodal synergistic therapeutic platform based on platinum-palladium-gold trimetallic alloy nanozymes (PPA). By overcoming the limitations of conventional photodynamic therapy (PDT) and electrodynamic therapy, such as restricted tissue penetration and operational complexity, this research integrates three advantageous strategies: photothermal therapy (PTT), chemodynamic therapy (CDT), and sonodynamic therapy (SDT) to construct a PPA system characterized by hierarchical nanostructures. The nanoplatform achieves efficient penetration through bacterial biofilm barriers attributed to its unique multi-branched architecture while exhibiting ultrasound (US)-laser dual-activated cascade catalytic effects and multimodal synergistic bactericidal mechanisms. Results demonstrate that PPA generates significant temperature gradients (with a photothermal conversion efficiency of 52.21 %) and bursts of reactive oxygen species (ROS) under combined near-infrared laser and US stimulation, effectively disrupting biofilm matrices and eradicating bacteria (with an inhibition ratio of 95 %). Integrated transcriptomic and proteomic analyses reveal that PPA operates through multiple mechanisms including the regulation of oxidative stress pathways, quorum sensing systems, and metabolic networks. Animal models illustrate the capability of PPA to accelerate deep infection wound healing while reducing inflammatory cytokine levels, alongside exhibiting excellent biocompatibility. This study transcends the limitations of traditional single-modal therapies by achieving precise synergy between nanozyme catalytic activity and physical field responses, establishing a novel "diagnosis-treatment-regulation" integrated paradigm for managing deep-seated tissue infections. Through engineered design and surface topological optimization, we successfully resolve the critical balance between nanozyme catalytic efficiency and biosafety, thereby laying the theoretical foundations for developing intelligent anti-infective materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.